Stilla Technologies

Stilla Technologies is a Paris-based European biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing biologists with tools for high-resolution genetic analysis.

Stilla Technologies was founded in 2013 and is now part of Bio-Rad Laboratories as LSG-Paris entity.

Since 2016, Stilla Technologies/Bio-Rad LSG-Paris is providing research organizations specialized in molecular biology and genetic analysis. LSG-Paris has developed a range of digital PCR instruments (Naica®, Nio® and now QX700™ systems), which, combined with microfluidic chips, dedicated reagents, and advanced data analysis software, allow the analysis of an unrivalled number of genetic biomarkers (multiplexing) with very high sensitivity and precision. This cutting-edge technology paves the way for new precision genetic tests in a wide range of applications such as liquid biopsy tests for cancer diagnostics, pre-natal testing, Gene Therapy, infectious disease or GMO detection.

Our multi-disciplinary teams in microfluidics, mechanical engineering, biology, and software shares a passion for building successful Life Science Products based on deep technological innovation. We aim to empower scientists with pioneering digital PCR solutions to build the future of genetic testing.

Stilla is now a Bio-Rad Laboratories Company.

Stilla is actively hiring talented and motivated individuals in Production, Manufacturing, Industrialization, Software & hardware Engineering, Molecular Biology etc...

If you are excited about the field of genomics and looking to building successful Life Science products based on deep technological innovation, join us!

• Be ready to work in a fast-paced environment and join a Life Science company growing at a 3-digit pace
• Enjoy solving “at the frontier” challenges in multidisciplinary teams
• Share a genuine passion for ‘omics’ and wish to contribute to improving health
• PhD or Master degree in ping-pong will be appreciated ;)